Table 1.
Ref.
|
Aim of the study
|
Modality
|
Patients
|
Method
|
AUC of the final model
|
Nie et al[7] | Differentiation between HCC and HCA | CT | 131 | ML | T: 0.96, V: 0.94 |
Nie et al[8] | Differentiation between HCC and FNH | CT | 156 | ML | T: 0.979, V: 0.917 |
Mokrane et al[9] | Differentiation between HCC and non-HCC nodules | CT | 178 | ML | T: 0.70, V: 0.66 |
Ponnoprat et al[10] | Differentiation between HCC and ICC | CT | 257 | ML | NA |
Shi et al[11] | Differentiation of HCC from other FLLs | CT | 342 | DL | 0.925 |
Yasaka et al[12] | Liver mass classification | CT | 560 | DL | 0.92 |
Cao et al[13] | FLL classification | CT | 375 | DL | V: 0.88-0.99 |
Jiang et al[14] | Comparing the diagnostic accuracies of EASL (v2018), LI-RADS criteria, and radiomics models for HCC | MRI | 211 | ML | T: 0.861, V: 0.810 |
Zhen et al[15] | Classification of liver tumors | MRI | 1411 | DL | 0.963-0.998 |
Liu et al[16] | Differentiation of cHCC-CC from CC and HCC | MRI | 85 | ML | 0.77 |
Huang et al[17] | Diagnosis of DPHCC | MRI | 100 | ML | 0.784 |
Jian et al[18] | Characterization of HCC | MRI | 112 | DL | NA |
Wu et al[19] | Classification of HCC and hepatic hemangioma | MRI | 369 | ML | T: 0.86, V: 0.89 |
T: Training cohort; V: Validation cohort; NA: Not available; AUC: The area under the receiver operating characteristic curve; ML: Machine learning; DL: Deep learning; HCC: Hepatocellular carcinoma; HCA: Hepatocellular adenoma; FNH: Focal nodular hyperplasia; ICC: Intrahepatic cholangiocarcinoma; cHCC-CC: Combined hepatocellular cholangiocarcinoma; CC: Cholangiocarcinoma; DPHCC: Dual-phenotype hepatocellular carcinoma; FLL: Focal liver lesion.